Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03272711 · ClinicalTrials.gov registry record · Phase 4
Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training
A Phase 4 study of Age-related Cognitive Decline, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT03272711 is a Phase 4 study of Age-related Cognitive Decline that has completed, run by Washington University School of Medicine. The registered enrollment target is 129 participants, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03272711, a Phase 4 study of Age-related Cognitive Decline, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to examine the potential benefits of vortioxetine in combination with at-home computerized cognitive training program to improve cognition, such as memory, attention, and concentration. This study will compare the effectiveness of vortioxetine plus cognitive training versus placebo plus cognitive training.
Conditions Studied
Interventions
- DRUG Vortioxetine 10 mg
- BEHAVIORAL Cognitive training program
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2016-08-31 |
| Est. Completion | 2019-01-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03272711
The ClinicalTrials.gov registry entry for NCT03272711 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Vortioxetine 10 mg is the first listed.
NCT03272711 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03272711 about?
NCT03272711 is a clinical study titled "Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training". The purpose of this research study is to examine the potential benefits of vortioxetine in combination with at-home computerized cognitive training program to improve cognition, such as memory, attention, and concentration. This study will compare the effectiveness of vortioxetine plus cognitive tra...
What is the current status of trial NCT03272711?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 129 participants. The study started on 2016-08-31. Estimated completion is 2019-01-24.
What conditions does trial NCT03272711 study?
This clinical trial studies the following conditions: Age-related Cognitive Decline.
What interventions are being tested in trial NCT03272711?
The interventions under investigation include: Vortioxetine 10 mg (DRUG), Cognitive training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03272711?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03272711 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Older Breast Cancer Patients: Risk for Cognitive Decline
RECRUITING
-
Acute Effects of THC in Older Adult
RECRUITING · Phase 1
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
RECRUITING · NA
-
Preventing Alzheimer's With Cognitive Training
RECRUITING · Phase 3
-
Cardiac-Control Affecting Learning Through Mindfulness (CALM)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.